Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases

References

• Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–19.
   PubMed Web of Science ®Google Scholar
• Clavenna A, Bonati M. Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch Dis Child. 2009;94(9):724–728.
   PubMed Web of Science ®Google Scholar
• Bárzaga Arencibia Z, López Leyva A, Mejías Peña Y, et al. Pharmacovigilance in children in Camagüey Province, Cuba. Eur J Clin Pharmacol. 2012;68(7):1079–1084.
   PubMed Web of Science ®Google Scholar
• Neubert A, Sturkenboom MCJM, Murray ML, et al. Databases for pediatric medicine research in Europe–assessment and critical appraisal. Pharmacoepidemiol Drug Saf. 2008;17(12):1155–1167.
   PubMed Web of Science ®Google Scholar
• Bénard-Laribière A, Jové J, Lassalle R, et al. Drug use in French children: a population-based study. Arch Dis Child. 2015;100(10):960–965.
   PubMed Web of Science ®Google Scholar
• Bozic B, Bajcetic M. Use of antibiotics in paediatric primary care settings in Serbia. Arch Dis Child. 2015;100(10):966–969.
   PubMed Web of Science ®Google Scholar
• Star K, Norén GN, Nordin K, et al. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf. 2011;34(5):415–428.
   PubMed Web of Science ®Google Scholar
• United Nations. Department of Economic and Social Affairs, Population Division (2013). World Population Prospects: The 2012 Revision, DVD Edition. 2013 [Cited 2015 Jun 04]; Available from: http://esa.un.org/unpd/wpp/Excel-Data/Interpolated.htm.
   Google Scholar
• Aagaard L, Hansen EH. Adverse drug reactions in children reported by European consumers from 2007 to 2011. Int J Clin Pharm. 2014;36(2):295–302.
   PubMed Web of Science ®Google Scholar
• Blake KV, Zaccaria C, Domergue F, et al. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Pediatric Drugs. 2014;16:309–319.
   PubMed Web of Science ®Google Scholar
• Ferrajolo C, Capuano A, Trifirò G, et al. Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001-2012. Expert Opin Drug Saf. 2014;13 Suppl 1(Suppl 1):S9–20.
   PubMed Web of Science ®Google Scholar
• Carnovale C, Brusadelli T, Zuccotti G, et al. The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy. Expert Opin Drug Saf. 2014;13 Suppl 1(Suppl 1):S1–8.
   PubMed Web of Science ®Google Scholar
• Aldea A, García Sánchez-Colomer M, Fernández Quintana E, et al. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009. Eur J Clin Pharmacol. 2012 Sep;68(9):1329–1338.
   PubMed Web of Science ®Google Scholar
• Hawcutt DB, Mainie P, Riordan A, et al. Reported paediatric adverse drug reactions in the UK 2000-2009. Br J Clin Pharmacol. 2012;73(3):437–446.
   PubMed Web of Science ®Google Scholar
• Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf. 2010;33(4):327–339.
   PubMed Web of Science ®Google Scholar
• Kimland E, Rane A, Ufer M, et al. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf. 2005;14(7):493–499.
   PubMed Web of Science ®Google Scholar
• Schirm E, Tobi H, Van Puijenbroek EP, et al. Reported adverse drug reactions and their determinants in Dutch children outside the hospital. Pharmacoepidemiol Drug Saf. 2004;13(3):159–165.
   PubMed Web of Science ®Google Scholar
• Clarkson A, Conroy S, Burroughs K, et al. Surveillance for adverse drug reactions in children: a paediatric regional monitoring centre. Paediatr Perinat Drug Ther. 2004;6(1):20–23.
   Google Scholar
• Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child. 2002;87(6):462–466.
   PubMed Web of Science ®Google Scholar
• Morales-Olivas FJ, Martínez-Mir I, Ferrer JM, et al. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol. 2000;53(10):1076–1080.
   PubMed Web of Science ®Google Scholar
• Lee W-J, Lee TA, Pickard AS, et al. Drugs associated with adverse events in children and adolescents. Pharmacotherapy. 2014;34(9):918–926.
   PubMed Web of Science ®Google Scholar
• Johann-Liang R, Wyeth J, Chen M, et al. Pediatric drug surveillance and the Food and Drug Administration’s adverse event reporting system: an overview of reports, 2003-2007. Pharmacoepidemiol Drug Saf. 2009;18(1):24–27.
   PubMed Web of Science ®Google Scholar
• Carleton BC, Smith MA, Gelin MN, et al. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol. 2007;14(1):e45–57.
   PubMedGoogle Scholar
• Moore TJ, Weiss SR, Kaplan S, et al. Reported adverse drug events in infants and children under 2 years of age. Pediatrics. 2002;110(5):e53.
   PubMed Web of Science ®Google Scholar
• Arencibia ZB, Sotomayor DN, Mollinedo NC, et al. Adverse drug reactions in children in Camagüey Province, Cuba. Arch Dis Child. 2010;95(6):474–477.
   PubMed Web of Science ®Google Scholar
• Li H, Guo X-J, Ye X-F, et al. Adverse drug reactions of spontaneous reports in Shanghai Pediatric Population. Plos One. 2014;9(2):e89829.
   PubMed Web of Science ®Google Scholar
• Granström M, Voordouw AC. Registration of influenza vaccines for children in Europe. Vaccine. 2011;29(43):7572–7575.
   PubMed Web of Science ®Google Scholar
• Shann F, Steinhoff MC. Vaccines for children in rich and poor countries. The Lancet. 1999;354:SII7–SII11.
   PubMed Web of Science ®Google Scholar
• Garfield CF, Dorsey ER, Zhu S, et al. Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr. 2012;12(2):110–116.
   PubMed Web of Science ®Google Scholar
• Backstrom M, Ekman E, Mjorndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol. 2007;63(6):613–618.
   PubMed Web of Science ®Google Scholar
• Ulfvarson J, Mejyr S, Bergman U. Nurses are increasingly involved in pharmacovigilance in Sweden. Pharmacoepidemiol Drug Saf. 2007;16(5):532–537.
   PubMed Web of Science ®Google Scholar
• Cliff-Eribo KO, Sammons H, Star K, et al. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012. Paediatr Int Child Health. 2015;0(0):2046905515Y.0000000059.
   Google Scholar
• Cliff-Eribo KO, Choonara I, Dodoo A, et al. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase. Expert Opin Drug Saf. 2015;14(12):1827–1833.
   PubMed Web of Science ®Google Scholar